AstraZeneca

OTC: AZNCF · Real-Time Price · USD
155.50
-0.25 (-0.16%)
At close: Aug 15, 2025, 3:42 PM
155.75
0.16%
After-hours: Aug 13, 2025, 08:00 PM EDT

AstraZeneca Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
56.5B 55.01B 54.04B 51.49B 49.42B 47.87B 46.12B 44.99B 44.48B 43.84B 44.35B 45.15B 44.04B 41.49B 37.42B 32.82B 29.53B 27.58B
Cost of Revenue
10.52B 11.2B 12.09B 12.74B 11.76B 10.56B 9.34B 8.86B 9.75B 10.79B 12.39B 14.12B 14.89B 14.08B 12.44B 9.34B 6.95B 5.74B
Gross Profit
45.98B 43.81B 41.96B 38.75B 37.66B 37.3B 36.78B 36.13B 34.74B 33.05B 31.96B 31.04B 29.15B 27.4B 24.98B 23.48B 22.58B 21.84B
Operating Income
11.32B 10.66B 10.22B 9.5B 9.35B 8.96B 8.28B 8.05B 7.34B 5.43B 3.76B 2.37B -549M 39M 1.06B 2.83B 5.68B 5.84B
Interest Income
401.15M 433.15M 458M 504.82M 422.82M 386.82M 353.82M 288M 202M 156M 95M 51M 51M 40M 43M 49M 41M 56M
Pretax Income
10.12B 9.39B 8.69B 7.95B 7.77B 7.46B 6.92B 6.78B 6.05B 4.21B 2.5B 1.09B -1.84B -1.32B -265M 1.54B 4.39B 4.59B
Net Income
8.37B 7.85B 7.04B 6.5B 6.44B 6.33B 5.96B 5.9B 6.16B 4.7B 3.29B 2.04B -1.25B -1.06B 112M 1.47B 3.77B 3.98B
Selling & General & Admin
20.42B 20.48B 20.53B 19.63B 19.27B 19.32B 18.89B 19.02B 18.49B 18.18B 18.95B 19.42B 18B 16.39B 14.46B 12.53B 11.82B 11.36B
Research & Development
14.51B 13.97B 13.49B 11.8B 11.27B 10.93B 10.85B 10.49B 10.26B 10.14B 9.66B 9.62B 9.41B 8.7B 8.28B 7.41B 6.71B 6.27B
Other Expenses
-272.95M -196.95M -128M -28M -3M 0.03 n/a n/a n/a n/a n/a n/a n/a n/a 1M 1M 1M 1M
Operating Expenses
34.66B 34.19B 32.78B 30.29B 29.35B 28.35B 28.75B 28.32B 27.47B 27.7B 28.04B 28.5B 29.35B 27.02B 23.58B 20.3B 16.75B 15.85B
Interest Expense
1.68B 1.69B 1.74B 1.77B 1.7B 1.69B 1.64B 1.55B 1.5B 1.38B 1.35B 1.3B 1.29B 1.31B 1.28B 1.28B 1.27B 1.28B
Selling & Marketing Expenses
563M 552M 555M 18.24B 18.22B 18.22B 18.22B 5.17B 5.17B 9.85B 14.68B 15.14B 18B 16.39B 14.46B 12.53B 11.82B 11.36B
Cost & Expenses
45.18B 44.42B 43.9B 42.06B 40.14B 38.91B 38.09B 37.18B 37.22B 38.49B 40.43B 42.62B 44.24B 41.1B 36.02B 29.64B 23.7B 21.59B
Income Tax Expense
1.73B 1.52B 1.65B 1.42B 1.3B 1.1B 936.38M 876M -118M -499M -792M -958M -588M -261M -380M 72M 624M 633M
Shares Outstanding (Basic)
1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.55B 1.5B 1.31B 1.31B
Shares Outstanding (Diluted)
1.56B 1.56B 1.56B 1.56B 1.56B 1.56B 1.56B 1.56B 1.56B 1.56B 1.56B 1.56B 1.56B 1.56B 1.55B 1.5B 1.32B 1.32B
EPS (Basic)
5.35 5.01 4.53 4.20 4.13 4.08 3.86 3.82 4.03 3.07 2.14 1.32 -0.84 -0.65 0.29 1.29 2.88 3.04
EPS (Diluted)
5.31 4.98 4.50 4.17 4.11 4.05 3.83 3.80 4.00 3.05 2.13 1.31 -0.84 -0.65 0.28 1.28 2.87 3.03
EBITDA
18.52B 17.69B 17.11B 15.36B 14.48B 14.21B 13.63B 13.33B 12.58B 10.58B 8.85B 8.38B 7.03B 7.03B 7.58B 7.93B 8.8B 8.94B
EBIT
11.7B 10.97B 10.43B 9.64B 9.34B 8.95B 8.37B 8.19B 7.45B 5.53B 3.78B 2.37B -542.38M 38.75M 1.07B 2.82B 5.66B 5.82B
Depreciation & Amortization
6.83B 6.72B 6.68B 5.71B 5.13B 5.14B 5.42B 5.58B 5.61B 5.63B 5.39B 6.06B 7.52B 6.95B 6.47B 5.06B 3.14B 3.11B